Cambridge Investment Research Advisors
PULM icon

Cambridge Investment Research Advisors’s Pulmatrix PULM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PULM Stock Details PULM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-510
Closed -$4K – 3277
2021
Q4 		$4K Hold
510
– – ﹤0.01% 3162
2021
Q3 		$8K Hold
510
– – ﹤0.01% 3080
2021
Q2 		$11K Hold
510
– – ﹤0.01% 3075
2021
Q1 		$14K Hold
510
– – ﹤0.01% 2853
2020
Q4 		$12K Hold
510
– – ﹤0.01% 2697
2020
Q3 		$12K Hold
510
– – ﹤0.01% 2505
2020
Q2 		$18K Buy
+510
New +$16.2K ﹤0.01% 2432

Other funds holding PULM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Investment Research Advisors's PULM Position: Q1 2022 in Review

Cambridge Investment Research Advisors sold out of Pulmatrix (PULM) in Q1 2022, closing a stake of 510 shares — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in PULM in Q2 2020 and held it in 7 quarters. The position peaked at $18K in Q2 2020. 14 funds tracked by Wall St. Rank hold PULM as of Q1 2022.

  • Cambridge Investment Research Advisors reported no remaining Pulmatrix position as of Q1 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 510 Pulmatrix shares in Q1 2022, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in Pulmatrix in Q2 2020 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Pulmatrix position peaked at $18K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Pulmatrix as of Q1 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.